2017 American Transplant Congress
Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.
Human leukocyte antigen-G (HLA-G) is a tolerogenic protein shown to contribute to allograft survival. Dimerized, soluble HLA-G (sHLA-Gd) has been shown to significantly prolong allograft…2017 American Transplant Congress
Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.
Cardiovascular disease remains the commonest cause of death in kidney transplant recipients. Although some studies suggest that Mammalian target of rapamycin (mTOR) inhibitors may reduce…2017 American Transplant Congress
The Clinical Significance of Red Cell Distribution Width (RDW) in Kidney Transplant Recipients.
1Seoul National University College of Medicine, Seoul, Korea; 2Asan Medican Center, Seoul, Korea
Background Increased red cell distribution width (RDW) has been known to be associated with worse prognosis in various populations. Although the levels of RDW are…2017 American Transplant Congress
Single Kidney Transplantation from Pediatric Donors Younger Than 3 Years to Adult Recipients.
Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Background: Traditionally, the criteria of splitting pediatric en bloc kidneys for transplantation into two adults includes: donor age > 3 years, donor weight > 12kg,…2017 American Transplant Congress
The Effect of Transplant Center Volume on Survival Outcomes for Patients Listed for Simultaneous Liver and Kidney Transplantation.
This study examines the effect of center volume on survival differences between Simultaneous Liver Kidney Transplantation (SLKT) and liver transplantation alone (LTA).Methods: The United Network…2017 American Transplant Congress
Delayed Calcineurin Inhibitor Introduction and Long Term Renal Outcomes in Liver Transplant Recipients Receiving Basiliximab Induction.
BACKGROUND Basiliximab may be used to delay the initation of calcineurin inhibitors (CNI) in patients with renal injury after liver transplantation (LT). The optimal time…2017 American Transplant Congress
Graft-versus-Host Disease Following Deceased Donor Liver Transplant.
Henry Ford Hospital, Detroit, MI
We reviewed our institutional experience with graft-versus-host disease (GVHD) following orthotopic liver transplantation (OLT). All OLT from 10/1/2013-10/1/2016 were reviewed. Five cases of GVHD were…2017 American Transplant Congress
Enhanced Recovery After Surgery Pathway for Living Donor Nephrectomy Patients Decreases Length of Stay and Narcotic Utilization.
Introduction:Enhanced recovery after surgery (ERAS) protocols reduce morbidity, hospital costs, and length of hospital stay although there have been few studies in living donor nephrectomy…2017 American Transplant Congress
Interruption of RAAS in Hypertensive Proteinuric Kidney Donors.
The aim of this analysis was to assess the progression of eGFR between proteinuric hypertensive living kidney donors (HTN-LKDs) receiving ACE inhibitors (ACEinh) or angiotensin…2017 American Transplant Congress
Prognostic Histopathologic Characteristics in Recurrent IgA Nephropathy: The Clinical Significance of Vascular Change.
Seoul National University Hospital, Seoul, Korea
Background Although recurrent IgA nephropathy (IgAN) after kidney transplantation is known to cause lgraft failure, the clinical significance of histopathologic parameters in allografts needs further…
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 181
- Next Page »